Skip to content

Firm Record

Lantheus Medical Imaging, Inc.

14 findings from 2 inspection documents published by regulators. Each row below says what its date means.

US FDA · Health Canada · 2026-03-09 ~ 2026-10-23

Areas cited

Laboratory and QC controlsMaterial and supplier controlComputer system validationDeviation, CAPA, and investigationLabeling and packagingQuality unit oversight

Published inspection documents

21 CFR sections cited in FDA inspections

Citations from 1 FDA inspection (2026-04-09) of facilities listed under this company name in FDA's inspection citation data.

As written by FDAInspectionLatest inspection
21 CFR 211.122(d)Label storage access limited to authorized personnel12026-04-09
21 CFR 211.125(a)Strict control not exercised over labeling issued12026-04-09
21 CFR 211.160(b)Scientifically sound laboratory controls12026-04-09
21 CFR 211.192Investigations of discrepancies, failures12026-04-09
21 CFR 211.22(d)Procedures not in writing, fully followed12026-04-09
21 CFR 211.68(b)Computer control of master formula records12026-04-09
21 CFR 211.84(d)(2)Reports of Analysis (Components)12026-04-09

1 site: Lantheus Medical Imaging, Inc. (North Billerica, MA, United States) · 1 inspection

Source: FDA Data Dashboard - Inspections Citations, as of 2026-11-08. Only inspections with at least one citation are included, and a section cited more than once in one inspection counts once. Only facilities whose name and legal form match this page's documents, and that are listed in a single country, are included.

Other companies with similar findings

Other companies with findings worded closely to this company's. Only documents of the same type are compared.

A record as of publication. Check the agency's own announcements for any later corrective action.

What is included. As collected on 2026-11-15: only documents with a detail page (3 or more findings). See the firm lookup for everything.

Full history of Lantheus Medical Imaging, Inc. — including inspection classifications Browse by document Go to Findings search
Weekly Newsletter

Get new findings like these every Monday

Every Monday we email the week's new findings and actions from the FDA, EMA, Health Canada and MFDS. Each one links to its record on our site, where you'll find the regulator's original document. We'll also let you know when the site gains new features. Unsubscribe any time with one click.

See recent findings first

Sent every Monday · a confirmation email follows when you subscribe · unsubscribe from the footer of any email.